ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year

December 8, 1995

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983

In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.

February 12, 1993

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994